✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Addiction MedicinePsychedelicsState PolicyCardiac SafetyResearch Why This MattersTexas joining state-level psychedelic research represents a...
Texas will launch its own clinical trials into ibogaine psychedelic after failing to find a drug …
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic PsychedelicsAddiction MedicineState PolicyClinical TrialsCardiology Why This MattersState-sponsored psychedelic research represents a significant shift...
Cannabis Use Disorder in the Era of Legalization: Implications for Addiction Treatment Systems
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Addiction MedicineCannabis Use DisorderPolicyThc PotencyTreatment Protocols Why This MattersAs cannabis legalization expands, clinicians are...
Do CBD Gummies Help with Smoking? What Users and Research Actually Show
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Smoking CessationCbdAddiction MedicineHarm ReductionEvidence-Based Medicine Why This MattersSmoking cessation remains one of the most...
Aelis Farma Reports Its 2025 Annual Financial Results and Confirms Its 2026 Outlook
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Cannabis Use DisorderCb1 ReceptorAddiction MedicinePharmaceutical DevelopmentWithdrawal Why This MattersAelis Farma is developing AEF0117, a...
Governor signs Ibogaine clinical trial bill into law – Magnolia Tribune
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Addiction MedicinePsychedelicsSubstance Use DisordersClinical TrialsPolicy Why This MattersIbogaine represents a potentially paradigm-shifting approach...
Relationally anchored motivation in alcohol and cannabis use disorder: a clinical case analysis
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Addiction MedicineCannabis Use DisorderTherapeutic ApproachRecovery MotivationDual Diagnosis Why This MattersThis case analysis explores how...
GLP-1 meds show promise for treating addiction – Futurity.org
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Addiction MedicineGlp-1 AgonistsSubstance Use DisorderPharmacotherapyReward Pathways Why This MattersGLP-1 receptor agonists like semaglutide and...
Stellate Ganglion Block for the Management of Cannabis Use Disorder: A Case Series
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Cannabis Use DisorderAddiction MedicineStellate Ganglion BlockInterventional ProceduresCase Series Why This MattersThis case series represents...
Evaluating cannabis substitution for alcohol within the context of a canadian managed alcohol program.
Managed Alcohol Programs (MAPs) provide beverage alcohol alongside housing and social supports to mitigate alcohol-related harms among individuals experienci…